Eur J Pharmacol 149, 171-174, (1988). Sharkey, J., Glen, K. A., Wolfe, S., & Kuhar, M. J. View abstract in PubMed Post navigationPreviousPrevious post:The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog.NextNext post:Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems.Related PostsAnavex Life Sciences Announces Initiation of First-in-Human Phase 1 Study of ANAVEX®3-71 (AF710B)May 21, 2020 Anavex Life Sciences Reports Fiscal 2020 Second Quarter Financial Results And Provides Business UpdatesMay 7, 2020Anavex Life Sciences to Announce Fiscal 2020 Second Quarter Financial Results on Thursday, May 7th, 2020May 5, 2020Anavex Life Sciences Reports Fiscal 2020 First Quarter Financial Results And Provides Clinical Study UpdatesFebruary 6, 2020
Anavex Life Sciences Announces Initiation of First-in-Human Phase 1 Study of ANAVEX®3-71 (AF710B)May 21, 2020
Anavex Life Sciences Reports Fiscal 2020 Second Quarter Financial Results And Provides Business UpdatesMay 7, 2020
Anavex Life Sciences to Announce Fiscal 2020 Second Quarter Financial Results on Thursday, May 7th, 2020May 5, 2020
Anavex Life Sciences Reports Fiscal 2020 First Quarter Financial Results And Provides Clinical Study UpdatesFebruary 6, 2020
